SCHEMBL3691126

SCHEMBL3691126

O=C(O)c1ccc(C2=C(O)C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.56
FGFR1 P11362 1/20 0.54
FGFR2 P21802 1/20 0.54
FGFR4 P22455 1/20 0.54
FGFR3 P22607 1/20 0.54
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.51
TTR P02766 1/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51
MAPK10 P53779 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
PTPRC P08575 2/20 0.50
LMNA P02545 2/20 0.50
XBP1 P17861 1/20 0.50
HKDC1 Q2TB90 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12280399 0.85 P2RX7 (0.69) P2RX7FGFR1FGFR2FGFR4FGFR3
SCHEMBL10068409 0.85 P2RX7 (0.74) P2RX7FGFR1FGFR2FGFR4FGFR3
SCHEMBL7101602 0.79 FGFR1 (0.57) P2RX7FGFR1FGFR2FGFR4FGFR3
Bilawsone SCHEMBL30884954 0.77 APAF1 (0.75) P2RX7ALDH1A1SMN1; SMN2MAPTNPC1
Bilawsone SCHEMBL3768549 0.77 APAF1 (0.75) P2RX7ALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL27645881 0.75 MAPT (0.86) P2RX7FGFR1FGFR2FGFR4FGFR3
SCHEMBL25390971 0.75 TSHR (0.62) TTRNPC1TP53RAB9AEGFR
Anthraquinone SCHEMBL2542462 0.75 TSHR (0.70) ALDH1A1MAPTTTRNPC1TP53
SCHEMBL14773924 0.75 ME2 (0.74) FGFR1FGFR2FGFR4FGFR3ALDH1A1
SCHEMBL13770821 0.74 FGFR1 (0.85) P2RX7FGFR1FGFR2FGFR4FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8241855-B2 Method for detecting cytosine methylations EPIGENOMICS AG (DE) 2012-08-14 US claimed
EP-1325154-B1 METHOD FOR THE DETECTION OF CYTOSINE METHYLATIONS EPIGENOMICS AG (DE) 2007-08-01 EP claimed
US-7118868-B2 Method for detecting cytosine methylations EPIGENOMICS AG (DE) 2006-10-10 US claimed
EP-1707642-A2 Method for detecting cytosine methylations Epigenomics AG (DE) 2006-10-04 EP claimed
EP-1294945-B1 METHOD FOR DETECTING CYTOSINE METHYLATIONS EPIGENOMICS AG (DE) 2006-08-30 EP claimed
US-20040152080-A1 Method for detecting cytosine methylations QIAGEN GMBH (DE) 2004-08-05 US claimed
EP-1294945-A2 METHOD FOR DETECTING CYTOSINE METHYLATIONS Epigenomics AG (DE) 2003-03-26 EP claimed
WO-2001098528-A2 METHOD FOR DETECTING CYTOSINE METHYLATIONS EPIGENOMICS AG (DE) 2001-12-27 WO claimed
US-8377638-B2 Process for the detection of cytosine methylations QIAGEN GMBH (DE) 2013-02-19 US disclosed
US-8241855-B2 Method for detecting cytosine methylations EPIGENOMICS AG (DE) 2012-08-14 US disclosed
US-20100297614-A1 PROCESS FOR THE DETECTION OF CYTOSINE METHYLATIONS QIAGEN GMBH (DE) 2010-11-25 US disclosed
EP-1977011-B1 PROCESS FOR THE DETECTION OF CYTOSINE METHYLATIONS QIAGEN GMBH (DE) 2010-07-28 EP disclosed
EP-1977011-A1 PROCESS FOR THE DETECTION OF CYTOSINE METHYLATIONS Qiagen GmbH (DE) 2008-10-08 EP disclosed
US-20070207472-A1 Method for detecting cytosine methylations QIAGEN GMBH (DE) 2007-09-06 US disclosed
EP-1325154-B1 METHOD FOR THE DETECTION OF CYTOSINE METHYLATIONS EPIGENOMICS AG (DE) 2007-08-01 EP disclosed
WO-2007077262-A1 PROCESS FOR THE DETECTION OF CYTOSINE METHYLATIONS QIAGEN GMBH (DE) 2007-07-12 WO disclosed
US-7118868-B2 Method for detecting cytosine methylations EPIGENOMICS AG (DE) 2006-10-10 US disclosed
EP-1707642-A2 Method for detecting cytosine methylations Epigenomics AG (DE) 2006-10-04 EP disclosed
EP-1294945-B1 METHOD FOR DETECTING CYTOSINE METHYLATIONS EPIGENOMICS AG (DE) 2006-08-30 EP disclosed
US-20040152080-A1 Method for detecting cytosine methylations QIAGEN GMBH (DE) 2004-08-05 US disclosed